The Transformation of Clinical Trial Strategies in the Era of Decentralized and Hybrid Opportunities
Sponsored by:
The pandemic disrupted oncology clinical trials, as investigators were often pulled away to care for COVID patients and many patients were uncomfortable coming into hospitals due to the risks of getting COVID.
Keep up with the top pharma business news of the week. On the go.
Sponsored by: